{"podcast":{"title":"BioSpace","slug":"biospace-6696251","podcast_index_feed_id":6696251,"rss_url":"https://api.riverside.fm/hosting/3SxyDAXU.rss","website_url":"https://www.biospace.com/","image_url":"https://hosting-media.riverside.com/media/imports/podcasts/a2a52916-bfe1-4f2a-b9a3-9be5029ecbe4/39510587-1699400129885-1e919ae7cb2aa.jpg","author":"BioSpace","episode_count":247,"summary":"Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.","last_synced_at":"2026-07-15T16:19:04.105662+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251"},"episodes":[{"title":"Biogen validates anti-tau approach at AAIC, psychedelics full speed ahead, ATTR-CM shakeup","slug":"biogen-validates-anti-tau-approach-at-aaic-psychedelics-full-speed-ahead-attr-cm-shakeup","published_at":"2026-07-15T07:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/biogen-validates-anti-tau-approach-at-aaic-psychedelics-full-speed-ahead-attr-cm-shakeup","url":"https://api.riverside.com/hosting-analytics/media/874db7e54d926518b357f18c70ab304281df29be048bb454375512d425cda6ef/eyJlcGlzb2RlSWQiOiI3Y2U0YWM1Yi1hYzQyLTRjYzYtODY4Mi1kYTFhNDI3OWRhZWYiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmE1Njg1OGYyY2UxMTM1ZGUxMDQ2YmI4L2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi03LTE0X18yMC01My0zLm1wMyJ9.mp3","duration_seconds":1282,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/biogen-validates-anti-tau-approach-at-aaic-psychedelics-full-speed-ahead-attr-cm-shakeup/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/biogen-validates-anti-tau-approach-at-aaic-psychedelics-full-speed-ahead-attr-cm-shakeup.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Bonus: Q2 2026 Job Market Update","slug":"bonus-q2-2026-job-market-update","published_at":"2026-07-14T07:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/bonus-q2-2026-job-market-update","url":"https://api.riverside.com/hosting-analytics/media/fea7d2736af2e53992474f3d5acf75f20e4808f70bfe44253451d766d29f758d/eyJlcGlzb2RlSWQiOiIyMWE2NmYwMC0wNWUxLTRkOGEtYTFhNC1kNzBhNTQ0NTk5ZjYiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmE1NGUzZDI1MzhlY2QzNTA5OTBkZmM2L2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi03LTEzX18xNS0xMC00MS5tcDMifQ==.mp3","duration_seconds":541,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/bonus-q2-2026-job-market-update/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/bonus-q2-2026-job-market-update.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"From sequence to scale: Gene editing’s new era in biologics manufacturing","slug":"from-sequence-to-scale-gene-editing-s-new-era-in-biologics-manufacturing","published_at":"2026-07-10T14:29:33+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/from-sequence-to-scale-gene-editing-s-new-era-in-biologics-manufacturing","url":"https://api.riverside.com/hosting-analytics/media/e6ef3999a4eebc7ff3d3fb7d2bd2283cc2faf6faa7941b683026532cd64aee24/eyJlcGlzb2RlSWQiOiIzNmJlMDE4OC02M2QxLTRmMzQtYmNlOS1iYzM0MzdmNzBjOTciLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmE1MTAyMTE4ZmM0NGVmMzc1MWUzM2MxL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi03LTEwX18xNi0zMC00MS5tcDMifQ==.mp3","duration_seconds":1241,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/from-sequence-to-scale-gene-editing-s-new-era-in-biologics-manufacturing/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/from-sequence-to-scale-gene-editing-s-new-era-in-biologics-manufacturing.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Vertex carries M&A uptick into H2, IPOs and VC raises also grow, FDA on pace despite turmoil","slug":"vertex-carries-m-a-uptick-into-h2-ipos-and-vc-raises-also-grow-fda-on-pace-despite-turmoil","published_at":"2026-07-08T07:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/vertex-carries-m-a-uptick-into-h2-ipos-and-vc-raises-also-grow-fda-on-pace-despite-turmoil","url":"https://api.riverside.com/hosting-analytics/media/296dbeabb7a5553c79e61442d4a88f512b65663f9d12071c7efc2033f8b4bd77/eyJlcGlzb2RlSWQiOiJlNmM5N2FhZi1iN2QyLTQzNTgtOGQ2NC02YTRjZTBjY2JlZmQiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmE0ZDQ4MjllMThiYTBmOTljZDljNWFlL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi03LTdfXzIwLTQwLTQxLm1wMyJ9.mp3","duration_seconds":1024,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/vertex-carries-m-a-uptick-into-h2-ipos-and-vc-raises-also-grow-fda-on-pace-despite-turmoil/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/vertex-carries-m-a-uptick-into-h2-ipos-and-vc-raises-also-grow-fda-on-pace-despite-turmoil.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Sentiment at BIO soars as FDA resets, dealmaking evolves; Amgen’s Tavneos in hot water","slug":"sentiment-at-bio-soars-as-fda-resets-dealmaking-evolves-amgen-s-tavneos-in-hot-water","published_at":"2026-07-01T08:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/sentiment-at-bio-soars-as-fda-resets-dealmaking-evolves-amgen-s-tavneos-in-hot-water","url":"https://api.riverside.com/hosting-analytics/media/d71aab074556b860062ff88723341d147218d8383bcd3182383c9739bfc92046/eyJlcGlzb2RlSWQiOiJiY2IzNzE4Ni00ZmQwLTQxZWMtOTgxYy02M2Y3ZjkyNjFiMGQiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmE0NDBlNWI1ZTk4OGU0ZmQ2MDEzOTI2L2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi02LTMwX18yMC00My0zOS5tcDMifQ==.mp3","duration_seconds":1374,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/sentiment-at-bio-soars-as-fda-resets-dealmaking-evolves-amgen-s-tavneos-in-hot-water/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/sentiment-at-bio-soars-as-fda-resets-dealmaking-evolves-amgen-s-tavneos-in-hot-water.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"The Golden Triangle and the gaps: Rethinking UK biotech","slug":"the-golden-triangle-and-the-gaps-rethinking-uk-biotech","published_at":"2026-06-25T07:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/the-golden-triangle-and-the-gaps-rethinking-uk-biotech","url":"https://api.riverside.com/hosting-analytics/media/3c9b72a356e85aaecbe0910a3bbebcf371e07ba918db3ae5816fc86bc34635ab/eyJlcGlzb2RlSWQiOiI0OGMyNzFkOC1kMTlmLTQ4ZjEtOGExNS1jNWQ0YzIxZGU5YTYiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmEzYzRhNzAyZjc3NjM2MDE1OGVhNWQwL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi02LTI0X18yMy0yMS01Mi5tcDMifQ==.mp3","duration_seconds":1177,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/the-golden-triangle-and-the-gaps-rethinking-uk-biotech/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/the-golden-triangle-and-the-gaps-rethinking-uk-biotech.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"AbbVie keeps M&A rolling, FDA’s reversal train chugs along, BIO 2026 dispatch, more","slug":"abbvie-keeps-m-a-rolling-fda-s-reversal-train-chugs-along-bio-2026-dispatch-more","published_at":"2026-06-24T07:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/abbvie-keeps-m-a-rolling-fda-s-reversal-train-chugs-along-bio-2026-dispatch-more","url":"https://api.riverside.com/hosting-analytics/media/97f8e54056a6111366b6e82fe09b8b0df10ab458f1efbc22359cfb12d9731dae/eyJlcGlzb2RlSWQiOiI3NDkwZjk3My03ZjYxLTQwMzktYmYyMC03YzFlNDg3YTFkNTUiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmEzYjA5MmNiMTMzYzVhZDRiNDFlMTFiL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi02LTI0X18wLTMxLTgubXAzIn0=.mp3","duration_seconds":1296,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/abbvie-keeps-m-a-rolling-fda-s-reversal-train-chugs-along-bio-2026-dispatch-more/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/abbvie-keeps-m-a-rolling-fda-s-reversal-train-chugs-along-bio-2026-dispatch-more.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"From fragile skin to living medicine: Lessons from RDEB","slug":"from-fragile-skin-to-living-medicine-lessons-from-rdeb","published_at":"2026-06-18T14:03:31+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/from-fragile-skin-to-living-medicine-lessons-from-rdeb","url":"https://api.riverside.com/hosting-analytics/media/7aa1c95d27d40b37390516f5787556880ff8488c150539e74e530b5b34670c2e/eyJlcGlzb2RlSWQiOiIyY2RiNzZhNC02NmRjLTRiZDMtYWQyNC0zMGU5NzcyMGE0NTMiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmEzM2ZhZTRmYjZmOGQ4M2VmYTFkYzdkL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi02LTE4X18xNi00LTIwLm1wMyJ9.mp3","duration_seconds":1303,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/from-fragile-skin-to-living-medicine-lessons-from-rdeb/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/from-fragile-skin-to-living-medicine-lessons-from-rdeb.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Moderna’s FDA adcomm, IPO mania, biopharma layoffs, more","slug":"moderna-s-fda-adcomm-ipo-mania-biopharma-layoffs-more","published_at":"2026-06-17T07:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/moderna-s-fda-adcomm-ipo-mania-biopharma-layoffs-more","url":"https://api.riverside.com/hosting-analytics/media/e7bb922ecd74ca99f6e7a22a6540717a4e3f8f3c899bcc523104932b683d3fcf/eyJlcGlzb2RlSWQiOiJmYTJhN2M5Ny02MTMxLTRiNmMtYWE5Yy04YmU3ZjkwNjhkZjQiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmEzMTk5ZDMyZDIwNmMwZDI2NThjMjUwL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi02LTE2X18yMC00NS0zOS5tcDMifQ==.mp3","duration_seconds":1533,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/moderna-s-fda-adcomm-ipo-mania-biopharma-layoffs-more/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/moderna-s-fda-adcomm-ipo-mania-biopharma-layoffs-more.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Portugal, Spain and the new biotech frontier","slug":"portugal-spain-and-the-new-biotech-frontier","published_at":"2026-06-10T23:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/portugal-spain-and-the-new-biotech-frontier","url":"https://api.riverside.com/hosting-analytics/media/c63bb6b2a2bfbcf3869341a8dcb2b9cbdf89f41bcc599ba8959d0fee66032b7b/eyJlcGlzb2RlSWQiOiJhNjU0NGQ5NS1iNjIxLTRmMTAtOGQ3Ny0xZjFhMjNlNDYwZmMiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmEyOTc1YzNmMjcwMjk3MzFjOTFmNTMxL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi02LTEwX18xNi0zMy0zOS5tcDMifQ==.mp3","duration_seconds":1233,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/portugal-spain-and-the-new-biotech-frontier/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/portugal-spain-and-the-new-biotech-frontier.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Lilly tees off with Novo at ADA, GSK’s $10.6B deal, FDA reform continues in Makary’s absence","slug":"lilly-tees-off-with-novo-at-ada-gsk-s-10-6b-deal-fda-reform-continues-in-makary-s-absence","published_at":"2026-06-10T07:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/lilly-tees-off-with-novo-at-ada-gsk-s-10-6b-deal-fda-reform-continues-in-makary-s-absence","url":"https://api.riverside.com/hosting-analytics/media/9c65f8f7a7c62f8242e0a6359b50fba61045ca32c38da7df9ad4251c8df73849/eyJlcGlzb2RlSWQiOiI0ZTgyMmZkYi03OThkLTRlNDktODZkOC1jN2MzMWUwOGMxMGUiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmEyODY1OWExMDBjMTVjNWJhYWJiYWUwL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi02LTlfXzIxLTEyLTI1Lm1wMyJ9.mp3","duration_seconds":1502,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/lilly-tees-off-with-novo-at-ada-gsk-s-10-6b-deal-fda-reform-continues-in-makary-s-absence/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/lilly-tees-off-with-novo-at-ada-gsk-s-10-6b-deal-fda-reform-continues-in-makary-s-absence.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Rethinking hair loss treatment","slug":"rethinking-hair-loss-treatment","published_at":"2026-06-03T23:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/rethinking-hair-loss-treatment","url":"https://api.riverside.com/hosting-analytics/media/73d4d606e42c9a64edf4618a9552f73113027cc79b3d80f88933008281a6417c/eyJlcGlzb2RlSWQiOiJmNWQ3YmM4ZC0xNmQ0LTRmODEtOTJhOS01YTFhNTczY2JkNmEiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmEyMDBiZDIxNGQ3Njg3ZjA1MDZhY2NmL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi02LTNfXzEzLTExLTE0Lm1wMyJ9.mp3","duration_seconds":1305,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/rethinking-hair-loss-treatment/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/rethinking-hair-loss-treatment.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"ASCO wins from RevMed, Akeso/Summit, more; plus more Lilly and more China; ADA on deck","slug":"asco-wins-from-revmed-akeso-summit-more-plus-more-lilly-and-more-china-ada-on-deck","published_at":"2026-06-03T09:48:40+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/asco-wins-from-revmed-akeso-summit-more-plus-more-lilly-and-more-china-ada-on-deck","url":"https://api.riverside.com/hosting-analytics/media/e3728c4669a6be447b94641b604fc8e84151e6abd0ff09a122ff3a47a9a90a7a/eyJlcGlzb2RlSWQiOiJhYTYwYjA1Zi02MGM2LTQ2MTYtOWRmOS03YTk3Yzc1MzU5ZDUiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmExZmY4N2VmYjViMGJhZGIzMTNmMjJhL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi02LTNfXzExLTQ4LTQ2Lm1wMyJ9.mp3","duration_seconds":1624,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/asco-wins-from-revmed-akeso-summit-more-plus-more-lilly-and-more-china-ada-on-deck/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/asco-wins-from-revmed-akeso-summit-more-plus-more-lilly-and-more-china-ada-on-deck.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"France’s biotech ecosystem: science, capital and scale","slug":"france-s-biotech-ecosystem-science-capital-and-scale","published_at":"2026-05-28T07:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/france-s-biotech-ecosystem-science-capital-and-scale","url":"https://api.riverside.com/hosting-analytics/media/78432452d425c03a67089fed6cc1beb4049361ea17549188bdb0141243930ef5/eyJlcGlzb2RlSWQiOiJmMzI3NTAyZC0yZDA5LTRiNGQtYTM1Zi0xYTJhOWM0ODQxOWMiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmExNmI4YTk4M2Q0MGQ1NWRmYjg0MjczL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi01LTI3X18xMS0yNi0xLm1wMyJ9.mp3","duration_seconds":1260,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/france-s-biotech-ecosystem-science-capital-and-scale/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/france-s-biotech-ecosystem-science-capital-and-scale.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Lilly wheels and deals, Moderna gets boost on hantavirus scare, ASCO excitement builds","slug":"lilly-wheels-and-deals-moderna-gets-boost-on-hantavirus-scare-asco-excitement-builds","published_at":"2026-05-27T07:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/lilly-wheels-and-deals-moderna-gets-boost-on-hantavirus-scare-asco-excitement-builds","url":"https://api.riverside.com/hosting-analytics/media/c3fae2ae3d7e7686d613d3115f802c2808f2a9166ebe9980aa6ebc099548a8df/eyJlcGlzb2RlSWQiOiJhODYzYTc0MS1hMWQ1LTRiOGUtOTQ1Ny1jMzEyYTVjMDY3ZTYiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmExNWUzMDlkZDY4ZTU0NjMxZDM3MmY3L2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi01LTI2X18yMC0xNC0zMy5tcDMifQ==.mp3","duration_seconds":1472,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/lilly-wheels-and-deals-moderna-gets-boost-on-hantavirus-scare-asco-excitement-builds/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/lilly-wheels-and-deals-moderna-gets-boost-on-hantavirus-scare-asco-excitement-builds.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Inside Germany’s biotech capital infrastructure and innovation engine","slug":"inside-germany-s-biotech-capital-infrastructure-and-innovation-engine","published_at":"2026-05-21T07:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/inside-germany-s-biotech-capital-infrastructure-and-innovation-engine","url":"https://api.riverside.com/hosting-analytics/media/68216bacc58a087b74d0216d50f11d8f16f70d0a53ec603f8c51603fc26f8365/eyJlcGlzb2RlSWQiOiI0MjkxYzAyZi03OGVmLTRlMDEtYjVkZi1jMWQxYTFlMDM0NDAiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmEwZGMzOTBmYmM4ZDFlNDI2MmY1OTIxL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi01LTIwX18xNi0yMi04Lm1wMyJ9.mp3","duration_seconds":1397,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/inside-germany-s-biotech-capital-infrastructure-and-innovation-engine/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/inside-germany-s-biotech-capital-infrastructure-and-innovation-engine.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"FDA’s absent leaders, the millions pharma CEOs make, and pancreatic cancer’s momentum","slug":"fda-s-absent-leaders-the-millions-pharma-ceos-make-and-pancreatic-cancer-s-momentum","published_at":"2026-05-20T07:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/fda-s-absent-leaders-the-millions-pharma-ceos-make-and-pancreatic-cancer-s-momentum","url":"https://api.riverside.com/hosting-analytics/media/8c492a4f29d03abf297145bda92373f95289c349495a2baf32f6b50d6db12cb6/eyJlcGlzb2RlSWQiOiJmNmYyNWYwZi1iNzg4LTQyNDQtODBhZS1iMWM2N2JiN2E3M2YiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmEwY2MxNzA5YzVlYWI4NDUwODYyMWFmL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi01LTE5X18yMi0wLTQ4Lm1wMyJ9.mp3","duration_seconds":1608,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/fda-s-absent-leaders-the-millions-pharma-ceos-make-and-pancreatic-cancer-s-momentum/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/fda-s-absent-leaders-the-millions-pharma-ceos-make-and-pancreatic-cancer-s-momentum.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"From MSCs to iPSCs: building the cell therapy future","slug":"from-mscs-to-ipscs-building-the-cell-therapy-future","published_at":"2026-05-14T07:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/from-mscs-to-ipscs-building-the-cell-therapy-future","url":"https://api.riverside.com/hosting-analytics/media/e3f666d25e76c7da4d3d0f0c9b9a3216ca9874f751649aba41dcced8868191e7/eyJlcGlzb2RlSWQiOiI5ZGIzNGY2NC1iMTZiLTQwYWQtYjRmZi01NjJmZTUzZDNiZjMiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmEwNGExZGFiMGUyMGEyMDQ0ZGE4YWMwL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi01LTEzX18xOC03LTU0Lm1wMyJ9.mp3","duration_seconds":1225,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/from-mscs-to-ipscs-building-the-cell-therapy-future/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/from-mscs-to-ipscs-building-the-cell-therapy-future.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay","slug":"makary-s-out-at-fda-sanofi-s-priority-voucher-issues-top-exec-pay","published_at":"2026-05-13T07:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/makary-s-out-at-fda-sanofi-s-priority-voucher-issues-top-exec-pay","url":"https://api.riverside.com/hosting-analytics/media/d96acc0ebb8b768ba7b31c0be63d427b96463499b72ec0ba40874027107f47be/eyJlcGlzb2RlSWQiOiIxNDcyODNkZS1mOTM3LTQ0NmQtYmY5Ny0zZDQwYjU3OWU2MTYiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmEwMzg1MGZkOWFkZmIxNjRmMTg5Zjg2L2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi01LTEyX18yMS01Mi00Ny5tcDMifQ==.mp3","duration_seconds":942,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/makary-s-out-at-fda-sanofi-s-priority-voucher-issues-top-exec-pay/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/makary-s-out-at-fda-sanofi-s-priority-voucher-issues-top-exec-pay.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Fibrosis, IPF and the search for better therapies","slug":"fibrosis-ipf-and-the-search-for-better-therapies","published_at":"2026-05-07T07:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/fibrosis-ipf-and-the-search-for-better-therapies","url":"https://api.riverside.com/hosting-analytics/media/3bb3ef6e9c30d3420c9158d73220f6f31ece48439f13eb7f09f0221bb66ee43d/eyJlcGlzb2RlSWQiOiJiMjcyNTkxNi0xOGY3LTRjZTctODMxYS0yNDdmZWQyNzU4Y2YiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNjlmYjBlZWI4ZDlkYmZjYTFhYzY3N2M0L2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi01LTZfXzExLTUwLTM1Lm1wMyJ9.mp3","duration_seconds":1080,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/fibrosis-ipf-and-the-search-for-better-therapies/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/fibrosis-ipf-and-the-search-for-better-therapies.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Pfizer, Lilly, more report Q1, FDA names acting CBER director and an ALS awakening","slug":"pfizer-lilly-more-report-q1-fda-names-acting-cber-director-and-an-als-awakening","published_at":"2026-05-06T10:16:27+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/pfizer-lilly-more-report-q1-fda-names-acting-cber-director-and-an-als-awakening","url":"https://api.riverside.com/hosting-analytics/media/844e44be32d480448091c3802b1825088ebf9bb027d68f9d7bac882db4300295/eyJlcGlzb2RlSWQiOiI2MTdmOGQwNS1hNDliLTQ0MDItODkzYS02OWY4NDhkZDE1ZWMiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNjlmYjE0MWUxMzZmOTcwNWRkNTEzN2RiL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi01LTZfXzEyLTEyLTQ2Lm1wMyJ9.mp3","duration_seconds":1350,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/pfizer-lilly-more-report-q1-fda-names-acting-cber-director-and-an-als-awakening/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/pfizer-lilly-more-report-q1-fda-names-acting-cber-director-and-an-als-awakening.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"What makes life science angel investment work?","slug":"what-makes-life-science-angel-investment-work","published_at":"2026-04-30T05:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/what-makes-life-science-angel-investment-work","url":"https://api.riverside.com/hosting-analytics/media/65c69fa239e2f1d7e387306e65496a3bc92ceef0c99b4a19b9723dc52aba6c41/eyJlcGlzb2RlSWQiOiI5NmY2Mjc0YS0wNmEyLTRmYzctYWVhYi02ZWYzM2IyNGIwMmQiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNjlmMGY1NDA4NWVlOTg3NTBlZDVlODY4L2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi00LTI4X18xOS01OC0yNC5tcDMifQ==.mp3","duration_seconds":1300,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/what-makes-life-science-angel-investment-work/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/what-makes-life-science-angel-investment-work.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Q1 earnings take off, Lilly strikes deals, Regeneron notches historic approval, FDA raises questions","slug":"q1-earnings-take-off-lilly-strikes-deals-regeneron-notches-historic-approval-fda-raises-questions","published_at":"2026-04-29T07:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/q1-earnings-take-off-lilly-strikes-deals-regeneron-notches-historic-approval-fda-raises-questions","url":"https://api.riverside.com/hosting-analytics/media/024be4efcf1c30f634c6d330bb4d80b3e264ab90bf3592ca63df504eaa98074c/eyJlcGlzb2RlSWQiOiJmNDYxMGVlYS0zNTM2LTRmYWUtYjA2My00NjQ3MTYyNjg5OWYiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNjlmMGZjN2RmNTVjZGQxNDExNjEwMTljL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi00LTI4X18yMC0yOS0xNy5tcDMifQ==.mp3","duration_seconds":1334,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/q1-earnings-take-off-lilly-strikes-deals-regeneron-notches-historic-approval-fda-raises-questions/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/q1-earnings-take-off-lilly-strikes-deals-regeneron-notches-historic-approval-fda-raises-questions.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"The next era of diabetes management","slug":"the-next-era-of-diabetes-management","published_at":"2026-04-23T07:50:23+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/the-next-era-of-diabetes-management","url":"https://api.riverside.com/hosting-analytics/media/7e7cc274bdf350b388b06c34c022a86a40c6aa201ec34db0dd49c372372dfcaa/eyJlcGlzb2RlSWQiOiI3NWU4MGRmNC1hMDE3LTQ3ZTItYTQwOS0zOWI5M2UxNWNjYzMiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNjllOWNmM2Y2ZmRjMTExNjcxOTc4NDQ1L2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi00LTIzX185LTUwLTIzLm1wMyJ9.mp3","duration_seconds":1302,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/the-next-era-of-diabetes-management/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/the-next-era-of-diabetes-management.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Trump’s psychedelics push, Lilly’s up to $7B CAR T deal, Replimune’s saga and Denali’s big win","slug":"trump-s-psychedelics-push-lilly-s-up-to-7b-car-t-deal-replimune-s-saga-and-denali-s-big-win","published_at":"2026-04-22T10:30:06+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/trump-s-psychedelics-push-lilly-s-up-to-7b-car-t-deal-replimune-s-saga-and-denali-s-big-win","url":"https://api.riverside.com/hosting-analytics/media/9617d3cd4fff909b991b8f0934743118f24807bd5ba35184ba401a6aace76ff7/eyJlcGlzb2RlSWQiOiJkYTVmZjg5Yy01NGQxLTQ3MTUtYWFjNy0zZWU3MzBkZDQ0ZTEiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNjllOGEyNDQ1ZDI2ZDFjN2IyYjcwN2I0L2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi00LTIyX18xMi0yNi0xMS5tcDMifQ==.mp3","duration_seconds":1568,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/trump-s-psychedelics-push-lilly-s-up-to-7b-car-t-deal-replimune-s-saga-and-denali-s-big-win/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/trump-s-psychedelics-push-lilly-s-up-to-7b-car-t-deal-replimune-s-saga-and-denali-s-big-win.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Funding the Future of European Biotech","slug":"funding-the-future-of-european-biotech","published_at":"2026-04-16T21:26:40+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/funding-the-future-of-european-biotech","url":"https://api.riverside.com/hosting-analytics/media/64ecc58072ed70e4cfc30a202812e46483bac6add04eb6f170850689a1ca241d/eyJlcGlzb2RlSWQiOiIzZGRmODhiZC0xMWI0LTQxMzEtYWY4YS0yM2I2Zjk0MGI3ZDciLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNjllMTU3YzgyOWNhNTMyMWJiMDEwOTQ3L2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi00LTE2X18yMy00Mi0zMi5tcDMifQ==.mp3","duration_seconds":1210,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/funding-the-future-of-european-biotech/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/funding-the-future-of-european-biotech.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"J&J targets $100B revenue, Replimune rebuffed again and a “Revolution” in pancreatic cancer","slug":"j-j-targets-100b-revenue-replimune-rebuffed-again-and-a-revolution-in-pancreatic-cancer","published_at":"2026-04-15T07:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/j-j-targets-100b-revenue-replimune-rebuffed-again-and-a-revolution-in-pancreatic-cancer","url":"https://api.riverside.com/hosting-analytics/media/3a694a4e30999817cbb9f4f6c3d70e304257ccd50cc5256018fff4e0f1f99eb6/eyJlcGlzb2RlSWQiOiJhOTg4YzliYi04ZWYxLTQxMWMtYWQwMS0yOTA1YjhkYTg4Y2QiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNjlkZThlODYxN2I0YzRlMzI0OWIyZDhkL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi00LTE0X18yMC01OS0xOC5tcDMifQ==.mp3","duration_seconds":1073,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/j-j-targets-100b-revenue-replimune-rebuffed-again-and-a-revolution-in-pancreatic-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/j-j-targets-100b-revenue-replimune-rebuffed-again-and-a-revolution-in-pancreatic-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Bonus: Q1 2026 Job Market Update","slug":"bonus-q1-2026-job-market-update","published_at":"2026-04-14T07:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/bonus-q1-2026-job-market-update","url":"https://api.riverside.com/hosting-analytics/media/0978c34794503eaddf66eb75748e828be425af2d458fc1d4f9849b7ef0d2c613/eyJlcGlzb2RlSWQiOiI0Y2Q5MTkyZi0yMzk1LTQ5MjEtOWU2Yy1hZTAyNDc0ZGZjNjQiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNjlkOTM4MGIzYzJmNmQ5N2VhMWY5YzVmL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi00LTEwX18xOS00OC01OS5tcDMifQ==.mp3","duration_seconds":513,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/bonus-q1-2026-job-market-update/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/bonus-q1-2026-job-market-update.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}]}